(Reuters) -Mikael Dolsten, Pfizer's former research and development chief, has withdrawn his candidacy for Novo Nordisk's board, citing personal reasons, the Danish drugmaker said on Thursday. Dolsten ...

Novo Nordisk said that Mikael Dolsten has decided to pull out from his proposed appointment to the company's board of directors for personal reasons. The Danish drugmaker is holding a special ...

NAPLES, Fla., Aug. 12, 2025 /PRNewswire/ -- MC Sciences, an emerging biotech developing first-in-class novel therapeutics backed by ROC Venture Group, proudly announces the appointment of Dr. Mikael ...

FILE PHOTO: Logos of Pfizer at the company’s booth at the 8th China International Import Expo (CIIE) in Shanghai, China, November 6, 2025.REUTERS/Maxim Shemetov/File Photo (Reuters) -Mikael Dolsten, ...